- Home
- RCKT vs LMAT Comparison
RCKT vs LMAT Comparison
Compare RCKT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- LMAT
- Stock Information
- Founded
- RCKT 1999
- LMAT 1983
- Country
- RCKT United States
- LMAT United States
- Employees
- RCKT N/A
- LMAT N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- LMAT Medical/Dental Instruments
- Sector
- RCKT Health Care
- LMAT Health Care
- Exchange
- RCKT Nasdaq
- LMAT Nasdaq
- Market Cap
- RCKT 1.3B
- LMAT 2.1B
- IPO Year
- RCKT N/A
- LMAT 2006
- Fundamental
- Price
- RCKT $12.72
- LMAT $91.47
- Analyst Decision
- RCKT Strong Buy
- LMAT Buy
- Analyst Count
- RCKT 11
- LMAT 7
- Target Price
- RCKT $50.27
- LMAT $92.83
- AVG Volume (30 Days)
- RCKT 1.6M
- LMAT 214.4K
- Earning Date
- RCKT 02-24-2025
- LMAT 02-25-2025
- Dividend Yield
- RCKT N/A
- LMAT 0.71%
- EPS Growth
- RCKT N/A
- LMAT 49.21
- EPS
- RCKT N/A
- LMAT 1.82
- Revenue
- RCKT N/A
- LMAT $213,029,000.00
- Revenue This Year
- RCKT N/A
- LMAT $16.04
- Revenue Next Year
- RCKT $233,736.97
- LMAT $9.62
- P/E Ratio
- RCKT N/A
- LMAT $50.16
- Revenue Growth
- RCKT N/A
- LMAT 14.81
- 52 Week Low
- RCKT $11.15
- LMAT $52.88
- 52 Week High
- RCKT $31.47
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- RCKT 47.75
- LMAT 37.50
- Support Level
- RCKT $11.56
- LMAT $91.28
- Resistance Level
- RCKT $12.32
- LMAT $94.21
- Average True Range (ATR)
- RCKT 0.71
- LMAT 2.69
- MACD
- RCKT 0.20
- LMAT -0.34
- Stochastic Oscillator
- RCKT 66.81
- LMAT 22.60
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.